Presmed Australia has been acquired by ICG
Advanced Health Limited has sold Presmed Australia Pty Ltd (PMA) to ICG.
PMA is a private day hospital group founded in 1997. Since 2014, it is majority-owned by Advanced Health, with the rest of the company owned by the long-standing Australian management team, directors and a consortium of specialist doctors. PMA co-owns ten key operating assets, which include day hospitals and consultation clinics, in partnership with the practicing doctors in those facilities. The facilities are located in and around Sydney and the Central Coast, both within New South Wales, and Tasmania. PMA’s facilities specialize in a range of surgical disciplines such as ophthalmology, ear nose and throat, pain management and oral maxillofacial surgery, as well as other aligned surgery types.
Headquartered in London, UK, and with over 30 years’ history, ICG is a global alternative asset manager providing flexible capital solutions to help companies develop and grow. The firm manages US$68.5 billion of assets and invests across the capital structure. ICG was founded in 1989, is a FTSE250-listed company regulated by the Financial Conduct Authority, and has offices in 15 countries across Europe, Asia and the US.
Advanced Health Limited is a public company listed on the Johannesburg Stock Exchange. The majority of the shares (68%) are owned by entities associated with the owner and founder, Carl Grillenberger.
Oaklins’ team in South Africa acted as corporate and designated advisor to Advanced Health Limited in this transaction.
联系交易团队
相关交易
Jeco Energies has sold a significant minority interest to NPM Capital
NPM Capital has acquired a significant minority interest in Jeco Energies. By teaming up with NPM Capital, Jeco Energies is ready for the next step in its remarkable growth trajectory and strengthening its position as the leading industrial energy solutions provider.
更多信息Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
更多信息Groupe JVS has completed an LBO with Capza and Bpifrance
The shareholders of Groupe JVS have completed an LBO with Capza and BpiFrance. Parquest sold their shares after partnering with the organization for three years. Groupe JVS’s management team will increase its ownership and remain as the majority shareholder of the group, alongside CAPZA and Bpifrance.
更多信息